ECOR electroCore, Inc.

NASDAQ
$9.97

electroCore, Inc. (ECOR) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.26 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +48.8% since its last earnings release on August 6, 2026.

electroCore Beat Consensus Estimates, Raises Guidance
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.26)
Rev est $10.96M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.10

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.

Sector

Healthcare

Industry

Medical Appliances/Equipment